Structure (Meprobamate 01)
Chemical structure diagram of Meprobamate, showing its molecular formula with amide and carbamate functional groups.*
Meprobamate Tablet
Product Images NDC 69097-975
3 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meprobamate (NDC 69097-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
200-100 (Meprobamate 02)
Meprobamate 200 mg oral tablets label shows the product name and strength prominently with a package count of 100 tablets. The label indicates it is manufactured by InvaGen Pharmaceuticals, a Cipla Ltd subsidiary, and labeled by Cipla USA Inc. The packaging includes dosage and storage information and features a QR code and a barcode.*
400-100 (Meprobamate 03)
Meprobamate Tablets, USP 400 mg oral tablets packaging label by Cipla USA Inc. The label displays a 100 tablet count with dosage strength prominently in a teal box. It includes manufacturer information for InvaGen Pharmaceuticals and Cipla USA, with storage instructions at controlled room temperature. The label also has NDC number 69097-975-07 and a QR code.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
